Abstract
An experimental murine ocular hypertension model with an open angle and optic nerve axon loss was produced with laser photocoagulation. This model provides a critical platform to investigate stem cell-based therapies aimed at restoring outflow pathway integrity for ocular hypertension and glaucoma.
Introduction
Glaucoma remains a leading cause of irreversible blindness worldwide. It is characterized by the progressive death of retinal ganglion cells (RGCs) and subsequent optic nerve atrophy, typically driven by elevated intraocular pressure (IOP). The primary site of resistance to aqueous humor outflow is the trabecular meshwork (TM). In Primary Open Angle Glaucoma (POAG), the most prevalent form, IOP rises despite the anterior chamber angle remaining physically open.
Developing effective treatments, particularly regenerative stem cell therapies, requires animal models that accurately replicate these human conditions. Many existing models either produce transient IOP spikes or result in "closed angles" (synechia), where the iris blocks the drainage pathway. This study describes a refined mouse model that achieves sustained, long-term IOP elevation while maintaining an open drainage angle, specifically designed for testing "bio-drainage" restorations.
Methodology
The study utilized adult C57BL/6 mice. To establish a statistically rigorous baseline, IOP was measured in a large cohort of 281 healthy mice using a rebound tonometer (TonoLab).
Model Induction
Ocular hypertension was induced using a 532-nm diode laser. Approximately 25 laser burns were delivered to the TM through the limbus. A second treatment was administered one week later to ensure sustained pressure elevation. Contralateral (untreated) eyes served as internal controls.
Validation and Assessment
The model was validated through several modalities:
- IOP Monitoring: Weekly measurements for up to 24 weeks.
- Structural Imaging: Spectral-domain optical coherence tomography (SD-OCT) confirmed the maintenance of an open anterior chamber angle in vivo. Transmission electron microscopy (TEM) was used to analyze the ultrastructural changes in the TM.
- Functional and Neural Assessment: Retinal ganglion cell health was monitored via the Photopic Negative Response (PhNR) in electroretinography (ERG). Neurodegeneration was quantified through semiautomatic counting of optic nerve axons.
- Biomarkers: Immunofluorescence tracked inflammatory markers (CD45) and proteins associated with fibrosis (SPARC).
Results
Sustained Ocular Hypertension
While the baseline IOP averaged approximately 14.5 mmHg, laser-treated eyes maintained an average IOP of >20 mmHg throughout the 24-week study period. By the end of the study, 57% of the experimental group maintained a mean IOP of 22.5 ± 2.5 mmHg.
Structural and Inflammatory Changes
SD-OCT imaging confirmed that 89% of treated eyes maintained a completely open angle, proving that the pressure rise resulted from internal TM dysfunction rather than mechanical blockage. TEM revealed that the juxtacanalicular tissue (JCT) lost its loose, organized structure, becoming compacted and dense. This was accompanied by an initial inflammatory response (CD45+ cells) and a long-term increase in SPARC expression, suggesting that laser-induced inflammation triggers fibrotic remodeling of the extracellular matrix (ECM).
Neurodegeneration and Functional Loss
The chronic elevation of IOP led to significant neurodegeneration. At 24 weeks, treated eyes showed a statistically significant 59% reduction in average optic nerve axon counts compared to controls. This physical damage correlated with a functional decline in RGCs, as evidenced by significantly decreased PhNR amplitudes.
Discussion
This laser-induced mouse model successfully replicates the key features of human POAG: chronic IOP elevation, an open drainage angle, and progressive optic nerve damage. The success rate of 57% for long-term maintenance highlights the biological variability inherent in such models but provides a robust framework for longitudinal studies.
The primary value of this model lies in its "open angle" pathology. Because the TM is damaged but remains accessible, it serves as an ideal environment for testing stem cell transplantation. Future research will focus on whether transplanted cells can home to the injured TM, remodel the fibrotic ECM, and restore natural aqueous humor drainage, potentially offering a curative approach to glaucoma.
Summary updated